Your session is about to expire
← Back to Search
Immunosuppression reduction for Immunosuppression
Study Summary
This trial is testing whether two new blood tests can help doctors safely convert patients from a dual immunosuppressive regimen to belatacept monotherapy.
- Immunosuppression
- Kidney Transplant Rejection
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 4 trial • 17 Patients • NCT04177095Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the approximate size of this medical experiment's participant pool?
"Unfortunately, this clinical trial has ceased its recruitment efforts. The details were uploaded on February 11th 2020 and the last amendment was made September 2nd 2021. As an alternative, there are currently 56 studies seeking participants with immunosuppression and 445 trials researching Immunosupression reduction that are actively looking for volunteers."
What other investigations have been conducted to gauge the efficacy of Immunosuppression reduction?
"Currently, 445 clinical trials exploring Immunosuppression reduction are ongoing. Out of those studies, 112 have progressed to the third phase of testing. Much of this research is being conducted in Duarte, California but there exist 20597 sites running these experiments worldwide."
Is there still capacity for new participants to join this research?
"Sadly, this clinical trial has already ended recruitment. It first began on February 11th 2020 and was last updated September 2nd 2021. However, there are still 56 studies searching for immunosuppressed participants and 445 trials actively recruiting patients who wish to reduce their Immunosuppression levels."
To what extent do the risks outweigh the benefits of immunosuppression reduction?
"Immunosuppression reduction has earned a score of 3, thanks to the Phase 4 status that confirms it is an approved medication."
To what medical afflictions is immunosuppression reduction commonly applied?
"Immunosuppression reduction is regularly used in the treatment of lung-related conditions. Additionally, this technique can be applied to combat advanced carcinoid tumor, ulcerative colitis, and varicella-zoster virus acute retinal necrosis."
Share this study with friends
Copy Link
Messenger